ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 104 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,197,963 | +57.3% | 248,398 | +100.0% | 0.01% | -14.3% |
| Q4 2021 | $2,669,000 | -67.3% | 124,198 | +12.4% | 0.01% | -69.6% |
| Q3 2021 | $8,161,000 | -29.9% | 110,493 | -48.1% | 0.02% | +35.3% |
| Q2 2021 | $11,638,000 | +66.7% | 212,844 | +124.8% | 0.02% | -19.0% |
| Q1 2021 | $6,983,000 | -2.7% | 94,698 | +13.7% | 0.02% | -8.7% |
| Q4 2020 | $7,179,000 | +154.1% | 83,278 | +11.3% | 0.02% | +130.0% |
| Q3 2020 | $2,825,000 | – | 74,851 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $715,272,000 | 67.97% |
| Logos Global Management LP | 3,156,981 | $232,796,000 | 22.72% |
| Vivo Capital, LLC | 4,220,048 | $311,186,000 | 10.94% |
| Foresite Capital Management IV, LLC | 785,945 | $57,956,000 | 6.94% |
| Foresite Capital Management V, LLC | 320,000 | $23,597,000 | 6.94% |
| Board of Trustees of The Leland Stanford Junior University | 518,822 | $38,258,000 | 3.38% |
| Cormorant Asset Management, LP | 881,770 | $65,022,000 | 1.45% |
| Redmile Group, LLC | 978,600 | $72,162,000 | 1.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 130,351 | $9,612,000 | 0.74% |
| Artal Group S.A. | 525,000 | $38,714,000 | 0.68% |